EGFR and neoplasm: Collectively our results suggested that EGFR, MAP2K1, mTOR, TEAD1, and YAP1 could mediate invasive tumor phenotypes and worsen prognoses via mechanisms involving both T-cell exclusion and dysfunctional phenotypes.